Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells

Journal of Nutrition

Volumn 140, Issue 9, 2010, Pages 1691-1697

  Karlsson, Erik A ^a   Sheridan, Patricia A ^a   Beck, Melinda A ^a  

^a University of North Carolina   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 7 RECEPTOR; LEPTIN; MESSENGER RNA; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BRONCHIOLE; CD8+ T LYMPHOCYTE; INFLUENZA; INFLUENZA VACCINATION; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; OBESITY; PRIMARY INFECTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DIETARY CARBOHYDRATES; DIETARY FATS; GENE EXPRESSION REGULATION; LUNG; MALE; MICE; MICE, INBRED C57BL; OBESITY; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTORS, LEPTIN; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

MUS;

EID: 77956597768     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.110.123653     Document Type: Article

References (78)

1. Bellisari A. Evolutionary origins of obesity. Obes Rev. 2008;9:165-80.
2. Jeffery RW, Harnack LJ. Evidence implicating eating as a primary driver for the obesity epidemic. Diabetes. 2007;56:2673-6.
3. Pi-Sunyer FX. The Obesity epidemic: pathophysiology and consequences of obesity. Obes Res. 2002;10:S97-104.
4. Pi-Sunyer FX. The medical risks of obesity. Obes Surg. 2002;12 Suppl 1:6S-11S.
5. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115:911-9.
6. Pond CM. Adipose tissue and the immune system. Prostaglandins, leukotrienes and essential fatty acids. 2005;73:17-30.
7. Li Z, Bowerman S, Heber D. Health ramifications of the obesity epidemic. Surg Clin North Am. 2005;85:681-701.
8. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis. 2006;6:438-46.
9. Jubber AS. Respiratory complications of obesity. Int J Clin Pract. 2004;58:573-80.
10. Canturk Z, Canturk NZ, Cetinarslan B, Utkan NZ, Tarkun I. Nosocomial infections and obesity in surgical patients. Obes Res. 2003;11:769-75.
11. Choban PS, Flancbaum L. The impact of obesity on surgical outcomes: a review. J Am Coll Surg. 1997;185:593-603. (Pubitemid 127469830)
12. Mito N, Hosoda T, Kato C, Sato K. Change of cytokine balance in diet-induced obese mice. Metabolism. 2000;49:1295-300.
13. Verwaerde C, Delanoye A, Macia L, Tailleux A, Wolowczuk I. Influence of high-fat feeding on both naive and antigen-experienced T-cell immune response in DO10.11 mice. Scand J Immunol. 2006;64: 457-66. (Pubitemid 44536330)
14. Lamas O, Marti A, Martinez J. Obesity and immunocompetence. Eur J Clin Nutr. 2002;56 Suppl 3:S42-5.
15. Nieman DC, Nehlsen-Cannarella SI, Henson DA, Butterworth DE, Fagoaga OR, Warren BJ, Rainwater MK. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord. 1996;20:353-60.
16. Nieman DC, Henson DA, Nehlsen-Cannarella SL, Ekkens M, Utter AC, Butterworth DE, Fagoaga OR. Influence of obesity on immune function. J Am Diet Assoc. 1999;99:294-9.
17. Tanaka S, Inoue S, Isoda F, Waseda M, Ishihara M, Yamakawa T, Sugiyama A, Takamura Y, Okuda K. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord. 1993;17:631-6. (Pubitemid 23340275)
18. Tanaka S-i, Isoda F, Kiuchi Y, Ikeda H, Mobbs CV, Yamakawa T. T lymphopenia in genetically obese-diabetic wistar fatty rats: effects of body weight reduction on T cells. Metabolism. 2000;49:1261-6.
19. Tanaka S-i, Isoda F, Yamakawa T, Ishihara M, Sekihara H. T lymphopenia in genetically obese rats. Clin Immunol Immunopathol. 1998;86:219-25.
20. CDC. Intensive-care patients with severe novel influenza A (H1N1) virus infection. Michigan, June 2009. Morb Mortal Wkly Rep. 2009;58:1-4.
21. Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, Gargiullo P, Belay B, Jain S, Cox C, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS ONE. 2010;5:e9694.
22. World Health Organization. 2003. WHO factsheet 211: influenza. Geneva, Switzerland. Available from: www.who.int/mediacentre/factsheets/2003/fs211/en/.
23. Murphy B, Webster R. Orthomyxoviruses in fields virology. Fields B, editor. 3rd ed. Philadelphia: Lippincott-Raven; 1997.
24. Karlsson EA, Sheridan PA, Beck MA. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J Immunol. 2010;184:3127-33.
25. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced type II diabetes in C57BL/6J mice. Diabetes. 1988;37:1163-7.
26. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffe-Scrive M. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism. 1995;44:645-51.
27. Smith AG, Sheridan PA, Harp JB, Beck MA. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr. 2007;137:1236-43.
28. Parekh PI, Petro AE, Tiller JM, Feinglos MN, Surwit RS. Reversal of diet-induced obesity and diabetes in C57BL/6J mice. Metabolism. 1998;47:1089-96.
29. Petro AE, Cotter J, Cooper DA, Peters JC, Surwit SJ, Surwit RS. Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse. Metabolism. 2004;53:454-7.
30. Kilbourne ED. Future influenza vaccines and the use of genetic recombinants. Bull World Health Organ. 1969;41:643-5.
31. Kreijtz JHCM, Bodewes R, van Amerongen G, Kuiken T, Fouchier RAM, Osterhaus ADME, Rimmelzwaan GF. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine. 2007;25:612-20. (Pubitemid 44856111)
32. Smith AG, Sheridan PA, Tseng RJ, Sheridan JF, Beck MA. Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus. Immunology. 2009;126:268-79.
33. Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine. 2007;25:6852-62.
34. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC. Cell-mediated protection in influenza infection. Emerg Infect Dis. 2006;12:48-54.
35. Bachmann MF, Beerli RR, Agnellini P, Wolint P, Schwarz K, Oxenius A. Long-lived memory CD8+ T cells are programmed by prolonged antigen exposure and low levels of cellular activation. Eur J Immunol. 2006;36:842-54.
36. Badovinac VP, Harty JT. Programming, demarcating, and manipulating CD8+ T-cell memory. Immunol Rev. 2006;211:67-80.
37. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708-12. (Pubitemid 129515761)
38. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science. 2001;291: 2413-7. (Pubitemid 32231804)
39. Liang S, Mozdzanowska K, Palladino G, Gerhard W. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J Immunol. 1994;152:1653-61.
40. Tough DF, Sun S, Zhang X, Sprent J. Stimulation of memory T cells by cytokines. Vaccine. 2000;18:1642-8.
41. Gray D. A role for antigen in the maintenance of immunological memory. Nat Rev Immunol. 2002;2:60-5.
42. Surh CD, Boyman O, Purton JF, Sprent J. Homeostasis of memory T cells. Immunol Rev. 2006;211:154-63.
43. Osborne LC, Abraham N. Regulation of memory T cells by [gamma]c cytokines. Cytokine. 2009;50:105-13.
44. Becker TC, Wherry EJ, Boone D, Murali-Krishna K, Antia R, Ma A, Ahmed R. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med. 2002;195:1541-8.
45. Schluns KS, Williams K, Ma A, Zheng XX, Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol. 2002;168:4827-31.
46. Judge AD, Zhang X, Fujii H, Surh CD, Sprent J. Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8+ T Cells. J Exp Med. 2002;196:935-46.
47. Marks-Konczalik J, Dubois S, Losi JM, Sabzevari H, Yamada N, Feigenbaum L, Waldmann TA, Tagaya Y. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci USA. 2000;97:11445-50.
48. Fehniger TA, Suzuki K, Ponnappan A, VanDeusen JB, Cooper MA, Florea SM, Freud AG, Robinson ML, Durbin J, et al. Fatal leukemia in Interleukin 15 transgenic mice follows early expansions in Natural Killer and memory phenotype CD8+ T Cells. J Exp Med. 2001;193: 219-32.
49. Alvarez B, Carbó N, López-Soriano J, Drivdahl RH, Busquets S, López- Soriano FJ, Argilés JM, Quinn LS. Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue. Biochim Biophys Acta. 2002;1570:33-7.
50. Frasca L, Stonier SW, Overwijk WW, Schluns KS. Differential mechanisms of memory CD8 T cell maintenance by individual myeloid cell types. J Leukoc Biol. Epub 2010 Apr 1.
51. Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15R[alpha] recycles and presents IL-15 in trans to neighboring cells. Immunity. 2002;17: 537-47.
52. Schluns KS, Klonowski KD, Lefrancois L. Transregulation of memory CD8 T-cell proliferation by IL-15R{alpha}+ bone marrow-derived cells. Blood. 2004;103:988-94.
53. Stonier SW, Ma LJ, Castillo EF, Schluns KS. Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation. Blood. 2008;112:4546-54.
54. Lam QLK, Liu S, Cao X, Lu L. Involvement of leptin signaling in the survival and maturation of bone marrow-derived dendritic cells. Eur J Immunol. 2006;36:3118-30.
55. Macia L, Delacre M, Abboud G, Ouk T-S, Delanoye A, Verwaerde C, Saule P, Wolowczuk I. Impairment of dendritic cell functionality and steady-state number in obese mice. J Immunol. 2006;177:5997-6006.
56. Banks AS, Davis SM, Bates SH, Myers MG. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem. 2000;275: 14563-72.
57. Frühbeck G. Intracellular signalling pathways activated by leptin. Biochem J. 2006;393:7-20.
58. Knobelspies H, Zeidler J, Hekerman P, Bamberg-Lemper S, Becker W. Mechanism of attenuation of leptin signaling under chronic ligand stimulation. BMC Biochem. 2010;11:2.
59. Howard JK, Cave BJ, Oksanen LJ, Tzameli I, Bjorbaek C, Flier JS. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med. 2004;10:734-8.
60. Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H, Torisu T, Chien KR, Yasukawa H, et al. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med. 2004;10:739-43.
61. Bjorbaek C, El-Haschimi K, Frantz JD, Flier JS. The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem. 1999;274:30059-65.
62. Bjørbæk C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell. 1998;1:619-25.
63. Starr R, Willson TA, Viney EM, Murray LJL, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, et al. A family of cytokine-inducible inhibitors of signalling. 1997;387:917-21.
64. Alexander WS. Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol. 2002;2:410-6.
65. Cohney SJ, Sanden D, Cacalano NA, Yoshimura A, Mui A, Migone TS, Johnston JA. SOCS-3 Is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol Cell Biol. 1999;19:4980-8.
66. Dalpke A, Heeg K, Bartz H, Baetz A. Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins. Immunobiology. 2008;213:225-35.
67. Starr R, Fuchsberger M, Lau LS, Uldrich AP, Goradia A, Willson TA, Verhagen AM, Alexander WS, Smyth MJ. SOCS-1 binding to tyrosine 441 of IFN-{gamma} receptor subunit 1 contributes to the attenuation of IFN-{gamma} signaling in vivo. J Immunol. 2009;183:4537-44.
68. Ilangumaran S, Ramanathan S, La Rose J, Poussier P, Rottapel R. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes. J Immunol. 2003;171: 2435-45.
69. Davey GM, Starr R, Cornish AL, Burghardt JT, Alexander WS, Carbone FR, Surh CD, Heath WR. SOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential. J Exp Med. 2005;202:1099-108.
70. Yang J-H, Lim H-S, Heo Y-R. Sasa borealis leaves extract improves insulin resistance by modulating inflammatory cytokine secretion in high fat diet-induced obese C57/BL6J mice. Nutr Res Pract. 2010;4:99-105.
71. Axelsson J, Heimbürger O, Lindholm B, Stenvinkel P. Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr. 2005;15:131-6.
72. Devaraj S, Kasim-Karakas S, Jialal I. The effect of weight loss and dietary fatty acids on inflammation. Curr Atheroscler Rep. 2006;8: 477-86.
73. Festa A, D'Agostino RJ, Williams K, Karter A, Mayer-Davis E, Tracy R, Haffner S. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25: 1407-15.
74. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab. 2005;19:547-66.
75. DeLany J. Leptin hormone and other biochemical influences on systemic inflammation. J Bodyw Mov Ther. 2008;12:121-32.
76. Howard JK, Flier JS. Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab. 2006;17:365-71.
77. Prele CM, Woodward EA, Bisley J, Keith-Magee A, Nicholson SE, Hart PH. SOCS1 regulates the IFN but not NF{kappa}B pathway in TLRstimulated human monocytes and macrophages. J Immunol. 2008;181: 8018-26.
78. Fujita Y, Murakami M, Ogawa Y, Masuzaki H, Tanaka M, Ozaki S, Nakao N, Mimori T. Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin Exp Immunol. 2002;128:21-6.